Clinical trial
Prospective, Multicenter Study on the Association Between Serum Ustekinumab Levels and Clinical, Biological and Endoscopic Remission in Patients With Crohn's Disease.
NCT07100093 is registered in ClinicalTrials.gov with Hospital Universitario La Paz as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective, Multicenter Study on the Association Between Serum Ustekinumab Levels and Clinical, Biological and Endoscopic Remission in Patients With Crohn's Disease.
- Lead sponsor
- Hospital Universitario La Paz
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 1, 2021
- Completion date
- February 25, 2022
- Enrollment
- 100 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ustekinumab serum levels in patients with crohn´s disease